Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma

NCT04479267 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma
High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements
High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6 Rearrangements
Double Expressor Lymphoma
High-grade B-cell Lymphoma

Interventions

DRUG: Prednisone
DRUG: Prednisolone
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Polatuzumab Vedotin
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]